(Total Views: 128)
Posted On: 10/20/2021 11:00:40 AM
Post# of 18400

$ATRX Adhera Therapeutics Expands Relationship with Melior Pharmaceuticals I, Adds NASH and Pulmonary Inflammation to Portfolio of Target Indications https://newsfilter.io/a/04b6807f110c83cd97fad9fe99bcb09e

